Managing Alzheimer's with Combination Care

Helping Maintain Quality of Life

As a caregiver, you probably want to do all you can to help slow the symptoms of Alzheimer's disease in your loved one. Combination therapy — Namenda® (memantine HCl)*+Aricept® (donepezil)**— is proven to help slow symptom progression better than Aricept alone.1

In a clinical trial published in the Journal of the American Medical Association, Namenda + Aricept (combination therapy) was shown to help moderate and severe Alzheimer's patients (as compared to those on Aricept alone):

  • Maintain the ability to perform daily activities such as grooming, finding belongings and conversing1,2
  • Delay the onset of agitation, aggression, irritability and other negative behavioral symptoms1,3
  • Improve and maintain thinking1,4

These benefits may help a person with Alzheimer's disease remain autonomous longer and help patients better connect with family and friends.

One question many caregivers have is, "How do I know if treatment is working?" In general, doctors consider combination therapy effective if the person with Alzheimer's disease shows an improvement in symptoms, no change in symptoms or a slower decline in symptoms.3

Remember, the goal of combination therapy, as with all Alzheimer's disease medications, is to provide as much quality of life as possible for everyone involved, especially your loved one. Sign up for the Combination Care for Alzheimer's Program to learn more about how combination therapy can help enhance your loved one's quality of life.

Sign up for the Combination Care for Alzheimer's Program

You'll receive:

  • Facts about the benefits of combination therapy
  • Tips on how to enhance the care of the person with Alzheimer's
  • A personalized Doctor Discussion Guide
Sign Me Up Now
  1. Tariot PN et al. JAMA. 2004
  2. Feldman H et al. ADAD. 2006
  3. Cummings JL et al. Neurology. 2006
  4. Schmitt et al. ADAD. 2006
  • *Namenda is indicated for the treatment of moderate to severe Alzheimer's disease. Namenda is manufactured by Forest Pharmaceuticals, Inc.
  • **Aricept is indicated for the treatment of mild, moderate, and severe Alzheimer's disease. Aricept is manufactured by Eisai Inc. and Pfizer Inc.